Clinical Trial Update: Study of OTO-104 in Subjects With Unilateral Meniere's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial results for OTO-104 in unilateral Meniere's disease have been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meniere Disease

Drugs mentioned

• OTO-104

Snippet

Sponsor: Otonomy, Inc. | Conditions: Meniere's Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-01-12